EI24P2

Across TCGA pan-cancer cohorts, EI24P2 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of EI24P2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where EI24P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EI24P2 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

COAD, LUAD, and STAD are the cancer types where EI24P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EI24P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.338	.003	4	view →
LUAD	Female	All	+0.093	.004	4	view →
STAD	All	II,III,IV	+0.282	.019	3	view →
THCA	Male	III,IV	−0.094	.020	2	view →
KICH	Male	All	−0.094	.047	1	view →
LIHC	All	All	+0.047	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

EI24P2–COAD

Open the COAD breakdown →